BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹40 Cr | ₹45 Cr | ₹41 Cr | ₹15 Cr | ₹9.56 Cr |
What is the latest Sundry Debtors ratio of BAFNA PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹40 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹41 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹9.56 Cr |
How is Sundry Debtors of BAFNA PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹40 Cr | -11.50 | |
| Mar2024 | ₹45 Cr | 10.32 | |
| Mar2023 | ₹41 Cr | 178.41 | |
| Mar2022 | ₹15 Cr | 54.60 | |
| Mar2021 | ₹9.56 Cr | - | |
Compare Sundry Debtors of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹331.7 Cr | -9.5% | -0.5% | 76.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -9.5% |
-0.5% |
76.3% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses